Oncogene Proteins, Fusion
"Oncogene Proteins, Fusion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The GENETIC TRANSLATION products of the fusion between an ONCOGENE and another gene. The latter may be of viral or cellular origin.
Descriptor ID |
D015514
|
MeSH Number(s) |
D12.776.602.500.500 D12.776.624.664.500
|
Concept/Terms |
Oncogene Proteins, Fusion- Oncogene Proteins, Fusion
- Fusion Oncogene Proteins
- Proteins, Fusion Oncogene
- Oncogene Proteins, Chimeric
- Fusion Proteins, Oncogene
- Oncogene Fusion Proteins
- Proteins, Oncogene Fusion
- Chimeric Oncogene Proteins
- Proteins, Chimeric Oncogene
- Chimeric Proteins, Oncogene
- Oncogene Chimeric Proteins
- Proteins, Oncogene Chimeric
|
Below are MeSH descriptors whose meaning is more general than "Oncogene Proteins, Fusion".
Below are MeSH descriptors whose meaning is more specific than "Oncogene Proteins, Fusion".
This graph shows the total number of publications written about "Oncogene Proteins, Fusion" by people in this website by year, and whether "Oncogene Proteins, Fusion" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2000 | 2 | 2 | 4 |
2001 | 1 | 1 | 2 |
2002 | 1 | 1 | 2 |
2003 | 3 | 1 | 4 |
2004 | 2 | 0 | 2 |
2005 | 4 | 0 | 4 |
2006 | 3 | 0 | 3 |
2007 | 0 | 1 | 1 |
2009 | 1 | 3 | 4 |
2010 | 3 | 2 | 5 |
2011 | 4 | 2 | 6 |
2012 | 3 | 2 | 5 |
2013 | 1 | 2 | 3 |
2014 | 2 | 3 | 5 |
2015 | 0 | 3 | 3 |
2016 | 4 | 6 | 10 |
2017 | 4 | 3 | 7 |
2018 | 4 | 1 | 5 |
2019 | 2 | 1 | 3 |
2020 | 2 | 2 | 4 |
2021 | 2 | 3 | 5 |
2022 | 0 | 6 | 6 |
2023 | 0 | 1 | 1 |
2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Oncogene Proteins, Fusion" by people in Profiles.
-
Adenoid Cystic Carcinoma with Sebaceous Differentiation and MYB::NFIB Fusion Arising in the External Auditory Canal. Head Neck Pathol. 2024 Sep 23; 18(1):85.
-
ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias. Blood Cancer J. 2023 03 23; 13(1):42.
-
Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma. Cancer Lett. 2023 01 01; 552:215984.
-
Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia. Blood. 2022 10 27; 140(17):1875-1890.
-
Updates on eosinophilic disorders. Virchows Arch. 2023 Jan; 482(1):85-97.
-
Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors. Histopathology. 2022 Nov; 81(5):670-679.
-
NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions. Am J Surg Pathol. 2022 12 01; 46(12):1706-1715.
-
Report of the First International Symposium on NUT Carcinoma. Clin Cancer Res. 2022 06 13; 28(12):2493-2505.
-
Primary Desmoplastic Small Round Cell Tumor of the Femur: Case Report and Review of a Rare Intraosseous Malignancy. Int J Surg Pathol. 2022 May; 30(3):317-325.
-
Uterine inflammatory myofibroblastic tumor: First report of a ROS1 fusion. Genes Chromosomes Cancer. 2021 12; 60(12):822-826.